Global markets for biochips to reach $14.3 billion by 2018

January 6, 2014

Biochip-based products have game-changing potential across a range of markets. Growth in next-generation sequencing-based diagnostics applications, use of lab-on-a-chip formats in point of care applications, and migration toward more integrated on-chip systems will impact everything from drug development to diagnostics. A shift in focus from R&D-related tools to clinical applications that are accurate, easy to use, low cost, and suitable for automation will drive tremendous growth in this market over the next five years.

BCC Research provides an in-depth analysis of the global biochip market for through its report Global Biochip Markets: Microarrays and Lab-on-a-Chip. According to the report, this market was valued at $3.3 billion in 2012 and is expected to increase to nearly $3.9 billion in 2013. BCC Research projects the market to reach $14.3 billion in 2018, and register a compound annual growth rate (CAGR) of 30% for the period 2013 to 2018.

Use this report to:

  • Gain an overview of the global market for current and emerging biochip technologies and products.
  • Analyze global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates through 2018.
  • Evaluate characterizations of biochip markets by type, function, and end-user.
  • Assess the main commercial biochip technologies and the commercial potential for each of the key market segments.
  • Examine factors that influence the market, including demand drivers, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs.
  • Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter, click here.

Advertisements

Global markets for biochips to reach $14.3 billion by 2018

January 2, 2014

Biochip-based products have game-changing potential across a range of markets. Growth in next-generation sequencing-based diagnostics applications, use of lab-on-a-chip formats in point of care applications, and migration toward more integrated on-chip systems will impact everything from drug development to diagnostics. A shift in focus from R&D-related tools to clinical applications that are accurate, easy to use, low cost, and suitable for automation will drive tremendous growth in this market over the next five years.

BCC Research provides an in-depth analysis of the global biochip market for through its report Global Biochip Markets: Microarrays and Lab-on-a-Chip. According to the report, this market was valued at $3.3 billion in 2012 and is expected to increase to nearly $3.9 billion in 2013. BCC Research projects the market to reach $14.3 billion in 2018, and register a compound annual growth rate (CAGR) of 30% for the period 2013 to 2018.

 RSS Feeds – Biotechnology

Use this report to:

  • Gain an overview of the global market for current and emerging biochip technologies and products.
  • Analyze global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates through 2018.
  • Evaluate characterizations of biochip markets by type, function, and end-user.
  • Assess the main commercial biochip technologies and the commercial potential for each of the key market segments.
  • Examine factors that influence the market, including demand drivers, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs.
  • Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter, click here.


Global Biochip Markets: Microarrays and Lab-on-a-Chip

July 26, 2012

The global biochips market for end users was $3.5 billion in the year 2010. The size of the biochips market will increase from $3.9 billion in 2011 to nearly $9.6 billion by 2016, a compound annual growth rate (CAGR) of 19.5%.
Learn about the types and potential applications of biochips in each major market segment (by type, function, and end user). Get information on global market trends, technology issues and market driving forces. Relevant company profiles are included as well…

Use this report to:

  • Determine the current and emerging biochip technologies and products to assess their worldwide growth potential over a 5-year period from 2011 to 2016
  • Understand the biochip market by type, function, and end user
  • Determine main commercial biochip technologies through the current and future commercial potential for the key market segments
  • Analyze industry competitiveness from 140 company profiles.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

SUMMARY FIGURE
GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, 2010-2016
($ MILLIONS)
Source: BCC Research


Global Biochips Market: Microarrays and Lab-On-A-Chip to Be Worth $6 Billion In 2014

January 6, 2010

Bookmark and Share

According to a new technical market research report from BCC Research (www.bccresearch.com), the global market value for biochip products is an estimated $2.6 billion in 2009, but is expected to increase to nearly $6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 17.7%.

The largest segment in the market, DNA microarrays, is expected to increase at a 5-year CAGR of 15.2%, from $1.3 billion in 2009 to $2.7 billion in 2014.

The second-largest segment, lab-on-a-chip products, is expected to reach $2.1 billion in 2014. The market in 2009 is estimated to be $817.6 million. Thus, the 5-year CAGR is projected to be a healthy 20.9%.

The third-largest segment, protein microarrays, is expected to increase in value from an estimated $343 million in 2009 to $848 million in 2014, for a 5-year CAGR of 19.8%.

The smallest segment of the biochips market, emerging microarrays, is expected to have the slowest growth rate. It’s projected CAGR is 15.1%, increasing in value from an estimated $131 million in 2009 to nearly $265 million in 2014.

Biochips currently are undergoing an important transition from primarily research-and-development tools to applied applications in next-generation sequencing, drug discovery and development, and clinical diagnostics. This shift toward clinical and applied markets is driven by large-scale efforts to associate genetic variation with disease susceptibility and progression. At the same time, miniaturization and integration of biochip devices is occurring. These factors drive down biochip costs, increase their portability, and validate their use as clinical diagnostics.

This report’s scope includes the major biochip technologies that are likely to become commercialized within 5 years. Influencing factors, including large-scale integration, microfluidics, nanotechnology, large-scale biochip, genomic and proteomic research initiatives, cancer diagnostic and treatment trends, and drug discovery and development needs, are discussed.

This study will be of particular interest to the companies in the following industries: diagnostics, pharmaceuticals, biotechnology, nanotechnology, life-sciences tools, biodefense, medical devices, polymers, glass, bioinformatics, and genetic services. It will also be of interest to companies involved in drug and/or biomarker discovery programs, manufacturers of microarrays and lab-on-a-chip devices, antibodies, restriction enzymes or primers, bioinformatics developers, and cancer researchers and clinicians.

Global Market for Biochips